Developing mRNA medicines to restore protein function.

We are a leading mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.

Learn More

Translate Bio

We are pioneering the translation of mRNA therapeutics into transformative medicines.

Watch the Video

Recent News

03.27 2020
Sanofi Pasteur and Translate Bio to Collaborate to Develop a Novel mRNA Vaccine Candidate Against COVID-19
03.26 2020
Translate Bio Provides MRT5005 Program Updates
03.12 2020
Translate Bio Announces Fourth Quarter and Full Year 2019 Financial Results and Highlights Recent Progress
02.26 2020
Translate Bio Receives FDA Fast Track Designation for MRT5005 for the Treatment of Cystic Fibrosis

View All

@TranslateBio